Agentic AI versus Generative AI: A Necessary Distinction
The healthcare industry has spent the past two years evaluating generative AI for documentation, summarization, and ambient clinical intelligence. These applications share a common architecture: a large language model receives a prompt, generates a response, and a human reviews the output before any action is taken. The human remains in the loop at every consequential decision point.
Agentic AI operates differently. An AI agent is a system that perceives its environment, reasons about a goal, selects actions from a repertoire of available tools, executes those actions, and evaluates the results — iteratively, without requiring human input at each step. In clinical contexts, this means an agent can retrieve a patient's medication history from the EHR, identify a contraindication, draft a provider notification, route it to the appropriate inbox, and document the action in the care record, all without a human initiating each individual step.
This distinction is not merely technical. It changes the nature of accountability, the governance requirements, and the risk surface of AI deployment in a clinical setting. Organizations that evaluate agentic AI using the same frameworks they applied to generative AI will encounter governance gaps with patient safety implications.
Clinical Use Cases Where Agentic AI Delivers Measurable Value
Prior authorization automation is among the most mature agentic use cases in healthcare. An agent can receive a referral order, retrieve the relevant clinical documentation from the EHR, populate the payer's prior authorization request using FHIR-based APIs, monitor the authorization status, and notify the care team upon adjudication — without manual data entry at any step. When integrated with FHIR APIs conformant to the Da Vinci PAS Implementation Guide, this workflow can reduce authorization processing time from days to hours.
Chronic disease monitoring presents a second high-value use case. An agent ingesting continuous glucose monitor data, activity metrics, and medication adherence records can identify early decompensation signals, generate a structured clinical summary using OBSERVATION archetype patterns, and route an alert to the care manager based on pre-defined escalation logic. The agent handles the data aggregation and pattern recognition; the clinician handles the clinical judgment.
Revenue Cloud and contract-based reimbursement workflows also benefit from agentic design. Agents can monitor authorization expiration dates, trigger renewal workflows, match authorization records against claims submission requirements, and flag discrepancies for billing team review — automating the administrative coordination layer between clinical care and payer operations without conflating it with clinical revenue cycle functions.
Governance Requirements for Agentic Clinical Systems
Agentic AI systems require governance frameworks that go substantially beyond what most health systems have built for their generative AI pilots. The core challenge is that an agent can take consequential actions faster than a human reviewer can intervene. Governance must therefore be embedded in the agent architecture, not bolted on afterward.
Three governance requirements are non-negotiable. First, every action taken by a clinical agent must be logged with sufficient granularity to reconstruct the agent's reasoning and the data it accessed at the time of each decision. This audit trail is both a regulatory requirement under HIPAA and a patient safety essential. Second, every agent must have defined intervention points where human review is required before actions with irreversible clinical consequences are executed. Drafting a provider notification is reversible. Canceling an active medication order is not. Third, agent behavior must be evaluated continuously against defined performance metrics that include not just task completion rates but clinical accuracy, escalation appropriateness, and false-positive rates on alert generation.
Organizations pursuing FedRAMP Authorized infrastructure for agentic AI deployment should plan for additional control mapping, particularly around automated system-to-system data access, least-privilege API permissions, and continuous monitoring of agent-initiated data queries. FedRAMP Authorized cloud environments provide a strong foundation, but the agentic application layer requires its own control documentation.
Deployment Considerations for Health Systems and Payers
Deploying an agentic AI system in a clinical environment requires integration architecture that most health systems have not yet built. The agent must be able to read from and write to the EHR through standards-based APIs, typically SMART on FHIR for authentication and FHIR R4 resources for data access. It must be able to invoke external services such as payer FHIR APIs, pharmacy benefit management systems, and clinical decision support services in a way that is auditable and reversible.
The orchestration layer — the component that sequences agent actions, manages state across multi-step workflows, and enforces governance guardrails — is where most of the implementation complexity resides. Platforms like Salesforce Agentforce provide managed orchestration capabilities that abstract some of this complexity, but health system deployments still require significant integration engineering to connect the agent to clinical source systems.
Start with a constrained scope. The most successful early agentic deployments in healthcare target a single, well-defined workflow with clear success metrics, established human escalation paths, and existing FHIR API infrastructure. Expanding scope incrementally, with governance review at each stage, is substantially safer than building a general-purpose clinical agent and defining its guardrails retroactively.